Anthropic Acquires One-Person Startup Mithril Medicine to Advance Drug Development
Anthropic acquired Mithril Medicine, a one-person startup whose routine work was handled by Claude agents. Its rare-disease drug programs are now Anthropic's first internal drug-development projects.
Anthropic has acquired Mithril Medicine, a one-person startup developing treatments for two rare pediatric genetic diseases: LAMA2-related congenital muscular dystrophy and alpha-dystroglycanopathy. These two programs are now Anthropic's first internal drug-development projects (Anthropic blog post).
According to founder Cody Tranbarger, the only staff employee, Claude agents handled most of the routine work: calculations, writing code, processing email, generating required files, and planning experiments. The agents took on nearly everything except decision-making and final <